Abstract: The methods and results of a set of cost-utility analyses conducted for the NICE Non-Alcoholic Fatty Liver Disease (NAFLD) and Cirrhosis guidelines, which were published in July 2016. These Markov models cover various diagnostic, and surveillance questions, including who should be tested, with which test and how frequently.
Cohorts included NAFLD, alcoholic liver disease, hepatitis B and hepatitis C. This presentation will focus on people with or at risk of NAFLD. The discussion will touch upon:
• The complexity of disease pathway modelling
• Interaction between patient choice and the results of cost-effectiveness analysis
• Incorporation of multiple NICE Single Technology Appraisals in to a clinical guideline model.
Biography: Having an academic background in economics and healthcare management, Lefteris has spent his career so far between providing methodological support to researchers applying for NIHR funding and developing national clinical guidelines primarily in the areas of liver disease and prisons’ healthcare.
Forthcoming External Talks
OxTalks (Oxford Population Health)
-
Defining genome structure at base pair resolution
Tuesday, 21 January 2025, 9.30am to 10.30am
Speakers: Dr James Davies
Venue: Big Data Institute, Old Road Campus OX3 7LF
-
BDI Seminar - Prediction of disease onset and progression using nationwide genetic and healthcare data
Thursday, 23 January 2025, 11am to 12pm
Speakers: Professor Andrea Ganna
-
Antimicrobial peptides in helminth secretions
Monday, 27 January 2025, 1pm to 2pm
Speakers: Prof Cinzia Cantacessi
Venue: Big Data Institute, Old Road Campus OX3 7LF